These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. COVID-19 in children: acute endotheliopathy, but forgotten prostacyclin replacement? Schranz D Cardiol Young; 2022 Apr; 32(4):572-573. PubMed ID: 34227929 [No Abstract] [Full Text] [Related]
8. The impact of nebulized epoprostenol and iloprost on hemoglobin oxygen affinity: an ex vivo experiment. Woyke S; Mair N; Haller T; Ronzani M; Plunser D; Oberacher H; Gatterer H; Rugg C; Ströhle M Am J Physiol Lung Cell Mol Physiol; 2022 Jun; 322(6):L898-L903. PubMed ID: 35503651 [TBL] [Abstract][Full Text] [Related]
9. Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension. Lang IM; Gaine SP Eur Respir Rev; 2015 Dec; 24(138):630-41. PubMed ID: 26621977 [TBL] [Abstract][Full Text] [Related]
10. Epoprostenol (Prostacyclin Analog) as a Sole Anticoagulant in Continuous Renal Replacement Therapy for Critically Ill Children With Liver Disease: Single-Center Retrospective Study, 2010-2019: Erratum. Pediatr Crit Care Med; 2024 Mar; 25(3):e175. PubMed ID: 38451807 [No Abstract] [Full Text] [Related]
11. Widening the Prostacyclin Paradigm: Tissue Fibroblasts Are a Critical Site of Production and Antithrombotic Protection. Vinokurova M; Lopes-Pires ME; Cypaite N; Shala F; Armstrong PC; Ahmetaj-Shala B; Elghazouli Y; Nüsing R; Liu B; Zhou Y; Hao CM; Herschman HR; Mitchell JA; Kirkby NS Arterioscler Thromb Vasc Biol; 2024 Jan; 44(1):271-286. PubMed ID: 37823267 [TBL] [Abstract][Full Text] [Related]
12. Prostacyclin facilitates vascular smooth muscle cell phenotypic transformation via activating TP receptors when IP receptors are deficient. Li Z; Luo W; Fang S; Chen X; Lin T; Zhou S; Zhang L; Yang W; Li Z; Ye J; Wang J; Liu P; Li Z Acta Physiol (Oxf); 2021 Feb; 231(2):e13555. PubMed ID: 32886850 [TBL] [Abstract][Full Text] [Related]
13. Strategies for optimizing intravenous prostacyclin-analog therapy in patients with pulmonary arterial hypertension. Ewert R; Habedank D; Halank M; Stubbe B; Opitz CF Expert Rev Respir Med; 2022 Jan; 16(1):57-66. PubMed ID: 34846985 [TBL] [Abstract][Full Text] [Related]
14. New regional drug delivery system by direct epicardial placement of slow-release prostacyclin agonist promise therapeutic angiogenesis in a porcine chronic myocardial infarction. Miyagawa S; Mizoguchi H; Fukushima S; Imanishi Y; Watabe T; Harada A; Sakai Y; Sawa Y J Artif Organs; 2021 Dec; 24(4):465-472. PubMed ID: 33761039 [TBL] [Abstract][Full Text] [Related]
15. The Acute Effects of Prostacyclin on Right Ventricular Contractility and Pulmonary Artery Coupling. Vanderpool RR; Insel M; Kubba S; Rischard FP Am J Respir Crit Care Med; 2023 Apr; 207(8):1100-1102. PubMed ID: 36689755 [No Abstract] [Full Text] [Related]
16. Muscle Injuries Induce a Prostacyclin-PPARγ/PGC1a-FAO Spike That Boosts Regeneration. Luo L; Chua YB; Liu T; Liang K; Chua MJ; Ma W; Goh JW; Wang Y; Su J; Ho YS; Li CW; Liu KH; Teh BT; Yu K; Shyh-Chang N Adv Sci (Weinh); 2023 Jul; 10(21):e2301519. PubMed ID: 37140179 [TBL] [Abstract][Full Text] [Related]
17. IP receptor-dependent activation of PPARgamma by stable prostacyclin analogues. Falcetti E; Flavell DM; Staels B; Tinker A; Haworth SG; Clapp LH Biochem Biophys Res Commun; 2007 Sep; 360(4):821-7. PubMed ID: 17624303 [TBL] [Abstract][Full Text] [Related]
18. An antiserum to 5,6-dihydro prostacyclin (PGI1) which also binds prostacyclin. Bunting S; Moncada S; Reed P; Salmon JA; Vane JR Prostaglandins; 1978 Apr; 15(4):565-73. PubMed ID: 353902 [TBL] [Abstract][Full Text] [Related]
19. Prostacyclin analogs stimulate VEGF production from human lung fibroblasts in culture. Kamio K; Sato T; Liu X; Sugiura H; Togo S; Kobayashi T; Kawasaki S; Wang X; Mao L; Ahn Y; Holz O; Magnussen H; Rennard SI Am J Physiol Lung Cell Mol Physiol; 2008 Jun; 294(6):L1226-32. PubMed ID: 18424619 [TBL] [Abstract][Full Text] [Related]